Citas bibligráficas
Celis, F., (2021). Uso de estatinas como factor protector para osteoporosis en pacientes adultos ambulatorios [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/8066
Celis, F., Uso de estatinas como factor protector para osteoporosis en pacientes adultos ambulatorios [Tesis]. PE: Universidad Privada Antenor Orrego - UPAO; 2021. https://hdl.handle.net/20.500.12759/8066
@mastersthesis{renati/374165,
title = "Uso de estatinas como factor protector para osteoporosis en pacientes adultos ambulatorios",
author = "Celis Becerra, Francis Baldemar",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2021"
}
Objective: To determine if the use of statins is a protective factor for osteoporosis in adult outpatients. Material and methods: Retrospective case-control study that included 300 patients over 40 years of age, fulfilling the selection criteria, divided into 2 groups: patients with and without osteoporosis; to whom the chi-square statistical test and odds ratio were applied respectively. Results: The mean age and the frequencies of gender, diabetes mellitus and obesity were significantly higher in the sample of patients with osteoporosis than in the sample without osteoporosis (p <0.05). The proportion of statin use in outpatient adult patients with osteoporosis was: 11%. The proportion of statin use in adult outpatient patients without osteoporosis was: 21%. The use of statins is a risk factor for osteoporosis with an odds ratio of 0.46 showing significance (p <0.05). In the multivariate study, the variables use of statins, diabetes mellitus, obesity, and female sex are known as determining factors for suffering from osteoporosis. Conclusion: The use of statins is a protective factor for osteoporosis in adult outpatients.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons